Patel, A.; Tong, S.; Lozada, K.; Awasthi, A.; Silverman, R.B.; Totonchy, J.; Yang, S.
Targeting Neuronal Nitric Oxide Synthase (nNOS) as a Novel Approach to Enhancing the Anti-Melanoma Activity of Immune Checkpoint Inhibitors. Pharmaceutics 2025, 17, 691.
https://doi.org/10.3390/pharmaceutics17060691
AMA Style
Patel A, Tong S, Lozada K, Awasthi A, Silverman RB, Totonchy J, Yang S.
Targeting Neuronal Nitric Oxide Synthase (nNOS) as a Novel Approach to Enhancing the Anti-Melanoma Activity of Immune Checkpoint Inhibitors. Pharmaceutics. 2025; 17(6):691.
https://doi.org/10.3390/pharmaceutics17060691
Chicago/Turabian Style
Patel, Anika, Shirley Tong, Kate Lozada, Amardeep Awasthi, Richard B. Silverman, Jennifer Totonchy, and Sun Yang.
2025. "Targeting Neuronal Nitric Oxide Synthase (nNOS) as a Novel Approach to Enhancing the Anti-Melanoma Activity of Immune Checkpoint Inhibitors" Pharmaceutics 17, no. 6: 691.
https://doi.org/10.3390/pharmaceutics17060691
APA Style
Patel, A., Tong, S., Lozada, K., Awasthi, A., Silverman, R. B., Totonchy, J., & Yang, S.
(2025). Targeting Neuronal Nitric Oxide Synthase (nNOS) as a Novel Approach to Enhancing the Anti-Melanoma Activity of Immune Checkpoint Inhibitors. Pharmaceutics, 17(6), 691.
https://doi.org/10.3390/pharmaceutics17060691
